Provided by Tiger Trade Technology Pte. Ltd.

Aptevo Therapeutics

6.92
-0.0650-0.93%
Volume:14.99K
Turnover:104.09K
Market Cap:6.90M
PE:-0.02
High:7.15
Open:6.90
Low:6.81
Close:6.98
52wk High:1,439.96
52wk Low:5.94
Shares:997.80K
Float Shares:750.50K
Volume Ratio:0.48
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-351.3949
EPS(LYR):-1,747.6642
ROE:-242.74%
ROA:-79.19%
PB:0.40
PE(LYR):0.00

Loading ...

Aptevo Therapeutics Announces CEO Transition and Leadership Changes

TIPRANKS
·
Feb 03

BRIEF-Aptevo Therapeutics Inc - Marvin White To Retire As Aptevo CEO Effective April 1, 2026 - SEC Filing

Reuters
·
Feb 03

Aptevo Therapeutics Inc - Marvin White to Retire as Aptevo CEO Effective April 1, 2026 - SEC Filing

THOMSON REUTERS
·
Feb 03

Aptevo Therapeutics ernennt Jeff Lamothe zum neuen CEO

Reuters
·
Feb 03

Aptevo Therapeutics Prospectus Relates To Offer And Sale Of Up To 7,075,471 Shares Of Our Common Stock By Selling Stockholder

Reuters
·
Jan 29

Aptevo Therapeutics Inc - Prospectus Relates to Offer and Sale of up to 7,075,471 Shares of Our Common Stock by Selling Stockholder - Filing

THOMSON REUTERS
·
Jan 29

Aptevo Therapeutics Secures $60 Million Equity Financing Facility

TIPRANKS
·
Jan 09

BRIEF-Aptevo Therapeutics On Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd

Reuters
·
Jan 09

Aptevo Therapeutics Inc - on Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd. - SEC Filing

THOMSON REUTERS
·
Jan 09

Aptevo Therapeutics Inc - Can Issue up to $60 Mln of Common Stock - SEC Filing

THOMSON REUTERS
·
Jan 09

Aptevo Therapeutics Secures $60 Million Equity Line of Credit from Yorkville Advisors

Reuters
·
Jan 09

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

Reuters
·
Dec 30, 2025

Top Midday Decliners

MT Newswires Live
·
Dec 27, 2025

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

Reuters
·
Dec 26, 2025

Aptevo Therapeutics Reports Strong Remission Rates and Safety for Mipletamig in Frontline AML Trial

Reuters
·
Dec 09, 2025

Aptevo Therapeutics Director Grady Grant III Acquires Common Shares

Reuters
·
Nov 13, 2025

Aptevo Therapeutics Unveils Preclinical Data for Trispecific Antibody APVO451 in Solid Tumors

Reuters
·
Nov 10, 2025

Aptevo Therapeutics management to meet virtually with Roth Capital

TIPRANKS
·
Nov 07, 2025

Aptevo Therapeutics reports Q3 EPS (23c) vs. ($357.86) last year

TIPRANKS
·
Nov 06, 2025

Aptevo Therapeutics Q3 EPS $(2.23) Misses $(2.09) Estimate

Benzinga
·
Nov 06, 2025